Coca Cola HBC AG (CCH)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 4,580.00 |
|---|---|
| 52-week range | 3,406.00 – 5,195.00 |
| Return, 1 month / 3 months | +3.9% / −7.8% |
| Return, 1 year / 3 years | +35.1% / +133.6% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 24.9% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 3,281.19M GBX |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Coca-Cola HBC bottles and distributes Coca-Cola drinks and other beverages across a broad group of countries in Europe, Africa and neighbouring regions. The company produces and sells sparkling soft drinks, water, juices, energy drinks and other non-alcoholic beverages, serving retailers, restaurants, hotels and other outlets through its distribution networks. It is based in Switzerland and operates as a bottling partner of the Coca-Cola system, making and delivering drinks to customers in the markets it covers.
Coca Cola HBC AG trades under the code CCH on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Coca Cola HBC AG (CCH) trades on the London Exchange in UK. It last closed at GBX 4,580.00 on 22 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 735 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.1% and over the last three months it fell 7.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.5% | ||
| From 52-week high | -11.4% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.8% | ||
| 6-month return | 11.1% | ||
| 12-month return, skipping the last month | 30.1% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,281.19M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | +3.9% |
| 3 months | −7.8% |
| 6 months | +11.1% |
| 1 year | +35.1% |
| 3 years | +133.6% |
| 5 years | +113.3% |
Signals
| 50-day / 200-day average | 4,458.80 / 4,425.91 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 89.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 May 2026 | GBP 1.0119 |
| 29 May 2025 | GBP 0.8685 |
| 30 May 2024 | GBP 0.7842 |
| 25 May 2023 | GBP 0.6577 |
| 7 Jul 2022 | GBP 0.5987 |
| 8 Jul 2021 | GBP 0.5397 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.